Botox Rival Stays on U.S. Market After Court Order; Evolus Rises


The cases are Allergan v. International Trade Commission, 21-1653, and Daewoong v. ITC, 21-1654, both U.S. Court of Appeals for the Federal Circuit (Washington). The ITC case is In the Matter of Certain Botulinum Toxin Products, 337-1145, U.S. International Trade Commission (Washington).

Source link